Consistently, CDR1as overexpression was significantly correlated with poorer DFS outcome in cancers (HR = 1.74; 95% CI, 1.33‐2.29; P < 0.001; I2 = 10%) (Figure 4B). The gene discussed is LINC00632; the disease is cancer.